Research News and Research

RSS
Perimenopausal women at greater risk for developing insomnia

Perimenopausal women at greater risk for developing insomnia

Gene therapy preserves vision in canine model of late-stage retinitis pigmentosa

Gene therapy preserves vision in canine model of late-stage retinitis pigmentosa

Poorly-designed animal study threatens validity of preclinical research

Poorly-designed animal study threatens validity of preclinical research

Specific gene signature could help predict survival outcomes among children with intermediate-risk RMS

Specific gene signature could help predict survival outcomes among children with intermediate-risk RMS

Computers can be as good as doctors and nurses in predicting patient discharges

Computers can be as good as doctors and nurses in predicting patient discharges

Researchers reveal effects of Affordable Care Act on low-income Virginians with HIV

Researchers reveal effects of Affordable Care Act on low-income Virginians with HIV

CWRU investigator receives $2.82 million NIH grant to make stealth bombs for brain cancer treatment

CWRU investigator receives $2.82 million NIH grant to make stealth bombs for brain cancer treatment

Only few doctors refer children with developmental delays to genetics specialists, say researchers

Only few doctors refer children with developmental delays to genetics specialists, say researchers

New blood test could help pair cancer patients with suitable therapy for their disease

New blood test could help pair cancer patients with suitable therapy for their disease

Having a high stress job may increase risk of stroke

Having a high stress job may increase risk of stroke

Bio-molecules present in human breast milk can help resolve inflammation, combat infection

Bio-molecules present in human breast milk can help resolve inflammation, combat infection

New $6.7 million project aims to help kidney dialysis patients live longer

New $6.7 million project aims to help kidney dialysis patients live longer

Novel ligand peptide-mimic inhibits abnormal overgrowth of blood vessels, may lead to new anti-cancer drugs

Novel ligand peptide-mimic inhibits abnormal overgrowth of blood vessels, may lead to new anti-cancer drugs

TxCell reviews its manufacturing strategy to focus on R&D and strategic partnerships - its core, high added value businesses

TxCell reviews its manufacturing strategy to focus on R&D and strategic partnerships - its core, high added value businesses

SRS microscope technology gives surgeons real-time microscopic vision of brain tumors

SRS microscope technology gives surgeons real-time microscopic vision of brain tumors

Different Crohn's disease treatments affect children's gut microbes in distinct ways

Different Crohn's disease treatments affect children's gut microbes in distinct ways

LEADERS FREE clinical trial demonstrates superior safety, efficacy for BioFreedom compared with bare-metal stent

LEADERS FREE clinical trial demonstrates superior safety, efficacy for BioFreedom compared with bare-metal stent

Merck unveils new global brand as a science and technology company

Merck unveils new global brand as a science and technology company

Researchers link organ transplant drug to rise in rare lymphoma

Researchers link organ transplant drug to rise in rare lymphoma

First-in-human compassionate use cases with Edwards' FORMA transcatheter tricuspid repair system presented at TCT

First-in-human compassionate use cases with Edwards' FORMA transcatheter tricuspid repair system presented at TCT

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.